Nearly all the industry's emissions happen upstream from core manufacturing functions. This puts sustainability almost entirely on the shoulders of purchasing.
- Why You Should Measure Comparability Debt Before Ever Starting A Study
- What FDA Inspectors Want From Your OOS File
- You Can't CAPA What You Can't Classify
- New USP Guidelines, Standards Address Lentivirus Characterization
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
- Bringing Next-Gen Sequencing To GMP Scale
- Risk Managing Through The Void Of ATMP Visible Particle Guidance
- Engineering CAR T Cells With mRNA-LNPs: Applying Oncology Learnings To Allergic Diseases
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Parallel Line Analysis And Relative Potency
Explore parallelism testing methods, including response and parameter comparison tests, with innovative software to ensure accurate results with detailed protocols for linear and non-linear regression curves.
-
A Beginner's Guide To Mesenchymal Stem Cell Culture
Gain a foundational understanding of the process for culturing mesenchymal stem cells in stirred-tank bioreactors and learn about the key parameters for successful scale-up.
-
Early Discovery Of Functional Antibody Leads
Early functional screening accelerates therapeutic antibody discovery, improving hit rates and efficiency through advanced platforms like hybridoma upgrades, single B cell workflows, and tailored phage display strategies.
-
Exploring Perfusion Technology For Virus Manufacturing Process Intensification
Perfusion cell culture technology supports high cell densities and product yields for viral vaccine manufacturing, offering a reliable way to produce high-quality cells at a commercial scale.
-
Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation
Growing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.
-
The Role Of Peptones In Boosting Monoclonal Antibody Production
Peptones have become a key tool in CHO cell bioprocessing, enhancing monoclonal antibody yield and quality.
-
Expansion Of Human Umbilical Cord-Derived MSCs
Discover how high-quality, multipotent stromal cells are efficiently produced for regenerative medicine. Learn about their impressive viability and critical marker expression for therapeutic uses.
-
Fluorescent Bacterial Colony Selection
Fluorescent reporter genes simplify screening bacterial transformants. Discover a system that automates colony picking to enhance efficiency and precision with fluorescence imaging.
-
An Adaptable, Intelligent Centerpiece For Customizable Manufacturing
Data from a CAR T cell manufacturing case study challenges the assumption that automated cell processing platforms and third-party expansion technologies are inherently incompatible.
-
Comparison Of Different Methods To Isolate HMW DNA From Bacteria
Different extraction methods produce dramatically different DNA sizes and qualities, directly affecting long‑read sequencing results. See how performing early QC can improve sequencing success.
NEWSLETTER ARCHIVE
- 09.24.26 -- OPCU Special CPHI Session: Trends Shaping Advanced Therapies
- 09.24.26 -- The Unspoken Truth About Cell Therapy Product Understanding
- 09.23.26 -- Europe's ATMP Opportunity Still Requires Local Navigation
- 09.22.26 -- How Regeneron Navigates Early Cell And Gene Therapy Quality Risks
- 09.22.26 -- Balancing Innovation With Manufacturability When Designing Next Generation Vectors
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
- Autoimmune CAR T Has Hit A Critical Moment. Are We Asking The Right Questions?
- Why Celcuity's REVTORPYK Creates A New Path For Precision Oncology
- In Vivo CAR T Needs More Than Better Cell Engineering
- Reimagining Solid Tumor Immunotherapy With SRC-3-Edited Tregs
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections